Indian Dermatology Online Journal

CASE REPORT
Year
: 2015  |  Volume : 6  |  Issue : 4  |  Page : 263--265

An atypical presentation of antiphospholipid antibody syndrome


Deepti D'Souza, Sukumar Dandakeri, M Ramesh Bhat, MK Srinath 
 Department of Dermatology, Father Muller Medical College Hospital, Mangalore, Karnataka, India

Correspondence Address:
Deepti D«SQ»Souza
Divya Sadan, Behind Nanthoor Cross, Kankanady Post, Mangalore - 575 002, Karnataka
India

Abstract

Cutaneous manifestations in antiphospholipid antibody syndrome (APS) though common, are extremely diverse and it is important to know which dermatological finding should prompt consideration of antiphospholipid syndrome. The cutaneous manifestations of APS vary from livedo reticularis to cutaneous necrosis, and systemic involvement is invariably an accomplice in APS. Cutaneous ulcers with sharp margins can be seen in APS and they are usually seen on the legs. This case had an atypical presentation, as the initial presentation was painful necrotic ulcers over the legs, which resembled pyoderma gangrenosum and she had no systemic manifestations. There was no history of any arterial or venous thrombosis or any abortions. Antiphospholipid syndrome can be tricky to diagnose when cutaneous lesions are atypical. Nonetheless, it is very important to pin down this syndrome early due to its systemic complications.



How to cite this article:
D'Souza D, Dandakeri S, Bhat M R, Srinath M K. An atypical presentation of antiphospholipid antibody syndrome.Indian Dermatol Online J 2015;6:263-265


How to cite this URL:
D'Souza D, Dandakeri S, Bhat M R, Srinath M K. An atypical presentation of antiphospholipid antibody syndrome. Indian Dermatol Online J [serial online] 2015 [cited 2021 Jan 25 ];6:263-265
Available from: https://www.idoj.in/text.asp?2015/6/4/263/160258


Full Text

 INTRODUCTION



The antiphospholipid antibody syndrome (APS) is a prothrombotic condition characterized by the presence of antiphospholipid antibodies in patients with recurrent morbidity during pregnancy and/or thromboembolic complications. [1] The cutaneous manifestations of APS vary from livedo reticularis to cutaneous necrosis. Ulcers resembling pyoderma gangrenosum (PG) have been described in APS and may cause confusion in diagnosis. It is important to be knowledgeable about APS as they can provide crucial information to uncover or confirm APS, and early diagnosis will spare patients from more serious consequences of the disease. [2]

 CASE REPORT



A 31 year old female presented with painful ulcers over legs since one month. The lesions initially occurred as painful hemorrhagic bullae, which broke to form exquisitely tender necrotic ulcers that had violaceous indurated borders [Figure 1]. Reddish painful lesions over the face and ears, pus-filled lesions over elbows, and bluish discoloration of a few digits were noted. She was also febrile and in poor general condition. Three months ago, she had transient loss of vision that lasted three days. There was no history of any precipitating factors, drug intake, chronic disease, peripheral vascular disease, or abortions. She had five children with no obstetric complications. However, the third delivery was a preterm delivery. We considered PG, ecthyma gangrenosum, and SLE. Investigations revealed elevated total leukocyte count, platelet count, erythrocyte sedimentation rate, and alkaline phosphatase. Activated partial thromboplastin time and prothrombin time were also mildly elevated. International normalized ratio (INR) was normal. Peripheral smear revealed neutrophilic leukocytosis with marked thrombocytosis. Serum electrolytes, renal function tests, chest radiography, ultrasound abdomen, blood culture, and echocardiography were normal. Fundoscopy was normal. Antinuclear antibody profile and pathergy test were negative. Tzanck smear showed neutrophils. Pus for culture and sensitivity showed scanty growth of Staphylococcus aureus. Rheumatoid factor was mildly elevated. Skin biopsy revealed a "sea of neutrophils" in the dermis suggestive of PG [Figure 2]. Staining with Periodic acid Schiff and Gomori methenamine silver stain was negative. Painful ulcers in a young female of child-bearing age prompted us to do further tests such as anticardiolipin antibodies and lupus anticoagulant test. Anticardiolipin antibody IgG, IgM were positive in high titers. The lupus anticoagulant test was positive. In view of the clinical and laboratory findings, we arrived at a final diagnosis of APS [Table 1].{Figure 1}{Figure 2}{Table 1}

She was treated with oral warfarin that was gradually increased after monitoring INR. The patient showed good improvement with treatment [Figure 3]. A repeat lupus anticoagulant test after 12 weeks was also positive confirming the diagnosis of APS.{Figure 3}

 DISCUSSION



Cutaneous manifestations in APS though common, are extremely diverse. It is important to know which dermatological finding should prompt a consideration of APS. Thrombosis, the main complication of APS, can affect vessels of nearly all sizes including dermal veins or arteries. [3] Cutaneous manifestations of APS include livedo reticularis, subungual splinter hemorrhages, digital necrosis, superficial venous thrombosis, post-phlebitis ulcers, circumscribed cutaneous necrosis, pseudovasculitis manifestations, extensive cutaneous necrosis, and primary anetoderma. [4] Cutaneous ulcers with sharp margins may be seen in APS, usually over the legs. About 40% of the patients have underlying multisystem thrombotic phenomena. [5] Pregnancy morbidity in the form of fetal loss or premature birth is a common finding in women with APS. Treatment includes aspirin, warfarin, and heparin.

This patient's presentation was atypical as she presented with painful necrotic ulcers over the legs that resembled PG with a suggestive histopathology. Pyoderma gangrenosum has not been mentioned as a cutaneous finding of APS. However, it is said that this syndrome is a highly problematic simulator of PG because of the low specificity of histologic findings in patients with the syndrome and its frequent response to systemic corticosteroids. Also, less than one third of patients with APS show histologic evidence of coagulopathy. [6] In contrast with most cases of APS where usually thrombocytopenia is seen, [7] our patient had an elevated platelet count. Combined treatment with oral corticosteroids, immunosuppression, acetylsalicylic acid, anticoagulation, and local measures in patients with APS and leg ulcers resembling PG has been tried, with success. [8] Our patient responded to anticoagulation with warfarin alone.

Our case had an atypical presentation in that the initial feature was painful necrotic ulcers over the legs that resembled pyoderma gangrenosum and she had no systemic manifestations. There was no history of any arterial or venous thrombosis or any abortions. Antiphospholipid syndrome can be tricky to diagnose when the cutaneous lesions are atypical. Nonetheless, it is very important to pin down this syndrome early due to its systemic complications.

References

1Lim W. Antiphospholipid antibody syndrome. Hematology Am Soc Hematol Educ Program 2009;233-9.
2Pinto-Almeida T, Caetano M, Sanches M, Selores M. Cutaneous manifestations of antiphospholipid syndrome: A review of clinical features diagnosis and management. Acta Reumatol Port 2013;38:10-8.
3Lee CW, Park MH. Flank ulcer in a patient with primary antiphospholipid syndrome. J Korean Med Sci 1999;14:110-2.
4Francès C, Niang S, Laffitte E, Pelletier Fl, Costedoat N, Piette JC. Dermatologic manifestations of the antiphospholipid syndrome: Two hundred consecutive cases. Arthritis Rheum 2005;52:1785-93.
5Rai R, Sekar CS, Kumaresan M. Antiphospholipid syndrome in dermatology: An update. Indian J Dermatol Venereol Leprol 2010:76:116-24.
6Weenig RH, Davis MD, Dahl PR, Su WP. Skin ulcers misdiagnosed as pyoderma gangrenosum. N Engl J Med 2002;347:1412-8.
7Gezer S. Antiphospholipid syndrome. Dis Mon 2003;49:696-741.
8Cañas CA, Durán CE, Bravo JC, Castaño DE, Tobón GJ. Leg ulcers in the antiphospholipid syndrome may be considered as a form of pyoderma gangrenosum and they respond favorably to treatment with immunosuppression and anticoagulation. Rheumatol Int 2010;30:1253-7.